|
Status |
Public on Mar 18, 2020 |
Title |
Benzo[a]pyrene and dibenzo[def,p]chrysene in 3D primary human bronchial epithelial cells [RNA-seq] |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
In this study, we assess potential differences in mechanism of action for two PAHs, benzo[a]pyrene (BAP) and dibenzo-[def,p]chrysene (DBC), in a primary human 3D bronchial epithelial culture (HBEC) model based on short-term biosignatures identified from global transcriptional profiling.
|
|
|
Overall design |
Fully differentiated bronchial epithelial cells (n=4 replicates) were treated with 500 µg/ml (19.80 nanomoles) benzo[a]pyrene (BAP), 10 µg/ml (0.35 nanomoles) dibenzo[def,p]chrysene (DBC) or acetone vehicle control for 48 hrs and isolated mRNA were sequenced on Illumina HiSeq 3000.
|
|
|
Contributor(s) |
Tilton SC |
Citation(s) |
31255691, 32890658 |
|
Submission date |
Mar 18, 2019 |
Last update date |
Oct 28, 2020 |
Contact name |
Susan C. Tilton |
E-mail(s) |
[email protected]
|
Organization name |
Oregon State University
|
Department |
AG Envr & Molec Toxicology
|
Street address |
1007 ALS Bldg
|
City |
Corvallis |
State/province |
OR |
ZIP/Postal code |
97331 |
Country |
USA |
|
|
Platforms (1) |
GPL21290 |
Illumina HiSeq 3000 (Homo sapiens) |
|
Samples (12)
|
|
Relations |
BioProject |
PRJNA527812 |
SRA |
SRP188728 |